Allogene Therapeutics, Inc. earnings per share and revenue

ALLO earnings per share for the last quarter are -0.38 USD whereas the estimation was -0.41 USD which accounts for 7.22% surprise. Företagets omsättning för samma period uppgår till 22.00 k USD trots den uppskattade siffran 11.23 k USD. Estimated earnings per share for the next quarter are -0.37 USD, and revenue is expected to reach 2.01 M USD. Also watch annual changes over time to get a bigger picture of ALLO earnings per share and revenue dynamics.